Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Teva
Federal Trade Commission
Accenture
Harvard Business School
Mallinckrodt
Medtronic
QuintilesIMS
Daiichi Sankyo
Johnson and Johnson

Generated: October 23, 2017

DrugPatentWatch Database Preview

DARICON Drug Profile

« Back to Dashboard

What is the patent landscape for Daricon, and what generic Daricon alternatives are available?

Daricon is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in DARICON is oxyphencyclimine hydrochloride. Additional details are available on the oxyphencyclimine hydrochloride profile page.

Summary for Tradename: DARICON

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list18
Patent Applications: see list59
Drug Prices:see details
DailyMed Link:DARICON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
DARICON
oxyphencyclimine hydrochloride
TABLET;ORAL011612-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Moodys
Accenture
Queensland Health
Cerilliant
Boehringer Ingelheim
Chubb
UBS
Colorcon
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot